Glycoform Ltd. aims to leverage the pioneering glyco-chemistry research of its Oxford University founders to develop targeted drug delivery systems and to improve the safety and efficacy of protein therapeutics, including monoclonal antibodies, by taking advantage of the way specific oligosaccharides, or sugar motifs, can affect the properties of the proteins they decorate.
Glycoform Ltd. aims to leverage the
pioneering glyco-chemistry research of its Oxford University
founders to develop targeted drug delivery systems and to improve
the safety and efficacy of protein therapeutics, including
monoclonal antibodies.
The firm hopes to take advantage of the way specific oligosaccharides, or sugar motifs, can affect the properties of the...